66 related articles for article (PubMed ID: 666456)
1. Cardiovascular and metabolic actions of an adenosine analogue (2'3'-o-methoxy-ethyliden-adenosine-5'-ethylcarboxamide) in the conscious dog.
Raberger G; Schütz W; Kraupp O
Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):150-7. PubMed ID: 666456
[TBL] [Abstract][Full Text] [Related]
2. Effects of a 2',3',5'-substituted adenosine derivative on systemic and coronary hemodynamics and on cardiac metabolism in the anesthetized dog.
Schütz W; Raberger G; Kraupp O
Arzneimittelforschung; 1978; 28(11):2079-82. PubMed ID: 582910
[TBL] [Abstract][Full Text] [Related]
3. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
4. [Effects of a long-acting adenosine analogue on insulin and glucagon release (author's transl)].
Schütz W; Bacher S; Raberger G
Wien Klin Wochenschr; 1980; 92(20):730-3. PubMed ID: 7008370
[TBL] [Abstract][Full Text] [Related]
5. Influence of aminophylline or beta-adrenoceptor blockade on glucagon release by a vasoactive adenosine analogue.
Schütz W; Raberger G; Kraupp O
Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):214-20. PubMed ID: 30423
[TBL] [Abstract][Full Text] [Related]
6. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs.
Fischer G; Schneider W; Krumpl G; Grohs JG; Raberger G
Arch Int Pharmacodyn Ther; 1989; 298():96-107. PubMed ID: 2757470
[TBL] [Abstract][Full Text] [Related]
7. Effects of the water extract of Chrysanthemum indicum Linn. on coronary and systemic hemodynamics in the dog.
Kato T; Noguchi K; Sakanashi M; Miyamoto Y; Suekawa M; Aburada M; Hosoya E
Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):241-53. PubMed ID: 3718087
[TBL] [Abstract][Full Text] [Related]
8. Coronary dilatory action of adenosine analogues: a comparative study.
Raberger G; Schütz W; Kraupp O
Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):140-9. PubMed ID: 603304
[TBL] [Abstract][Full Text] [Related]
9. The potentiation of the activity of adenosine on coronary blood flow, blood pressure and heart rate by inosine in the dog.
Komarek J; Parish GA
Arzneimittelforschung; 1975 May; 25(5):737-40. PubMed ID: 1242314
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular actions of buflomedil and possible mechanisms involved.
Kushiku K; Ohba M; Mikagi T; Nuki S; Araki Y; Furukawa T
Arzneimittelforschung; 1989 Jun; 39(6):670-7. PubMed ID: 2775333
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of three calcium entry blockers in conscious dogs.
Eigenmann R; Gerold M
Arzneimittelforschung; 1987 Sep; 37(9):1020-5. PubMed ID: 3435596
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of adenosine-5'-carboxylic acid-amide in the anaesthetized dog during normal respiration and hypercapnic acidosis.
Schütz W; Raberger G
Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):140-8. PubMed ID: 1267538
[TBL] [Abstract][Full Text] [Related]
15. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs.
Zhao G; Linke A; Xu X; Ochoa M; Belloni F; Belardinelli L; Hintze TH
J Pharmacol Exp Ther; 2003 Oct; 307(1):182-9. PubMed ID: 12954805
[TBL] [Abstract][Full Text] [Related]
16. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
Shen YT; Pittman TJ; Buie PS; Bolduc DL; Kane SA; Koblan KS; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
18. General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
Maxwell GM
Arch Int Pharmacodyn Ther; 1968 May; 173(1):226-31. PubMed ID: 5657822
[No Abstract] [Full Text] [Related]
19. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
